Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Public Health|July 9, 2024
Influence of non-pharmaceutical interventions during the COVID-19 pandemic on respiratory viral infections - a prospective population-based cohort studyNadja Käding, Frederike Waldeck, Bjarne Meier, et al.
NPJ Parkinson'S Disease|January 10, 2026
Metabolomic breath landscape analysis unravels lipid biomarker candidates in patients with genetic and idiopathic Parkinson's diseaseMadiha Malik, Norbert Brüggemann, Tatiana Usnich, et al.
Neurological Research and Practice|June 21, 2021
Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19Max Borsche, Dirk Reichel, Anja Fellbrich, et al.
Stem Cell Research|November 10, 2019
Generation and characterization of human-derived iPSC lines from three pairs of monozygotic twins discordant for Parkinson's diseaseMarija Dulovic-Mahlow, Agnieszka Lukomska, Sokhna Haissatou Diaw, et al.
NPJ Parkinson'S Disease|October 31, 2023
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s diseaseSokhna Haissatou Diaw, Max Borsche, Linn Streubel-Gallasch, et al.
Immunology|October 22, 2019
Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulationJanina M Kuehlwein, Max Borsche, Patricia J Korir, et al.
Cerebellum (London, England)|April 21, 2023
POLG2-Linked Mitochondrial Disease: Functional Insights from New Mutation Carriers and Review of the LiteratureMax Borsche, Marija Dulovic-Mahlow, Hauke Baumann, et al.
NPJ Parkinson'S Disease|July 14, 2023
Depressive symptoms in Parkinson's disease are insufficiently but more often treated than in other chronic conditionsTatiana Usnich, Björn Hauptmann, Henrike Hanssen, et al.
Movement Disorders Clinical Practice|March 15, 2024
RFC1 and FGF14 Repeat Expansions in Serbian Patients with Cerebellar AtaxiaAndona Milovanović, Nataša Dragaševic-Mišković, Mirja Thomsen, et al.
Frontiers in Neurology|August 26, 2021
Frequency of Heterozygous Parkin (<i>PRKN</i>) Variants and Penetrance of Parkinson's Disease Risk Markers in the Population-Based CHRIS CohortMaria Paulina Castelo Rueda, Athina Raftopoulou, Martin Gögele, et al.
Pageof 5